Grant of stock options to officers and employees
First written in FY2019-Q2. 13 of 14 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「The disposal of treasury shares as restricted stock compensation, based on a resolution of the Board of Directors meeting held on 26 February 2026, reduced the number of shares by 36,450.」
Treasury shares were disposed of as restricted stock compensation, reducing the number of treasury shares by 36,450. - FY2025-H1Disposal of Treasury Shares as Restricted Stock CompensationAnnual report
「Treasury shares decreased by 23,798 as a result of the disposal of treasury shares as restricted stock compensation pursuant to a resolution of the Board of Directors adopted on 26 February 2025.」
Separate from the stock options, treasury shares were disposed of as restricted stock compensation, reducing the number of treasury shares by 23,798. - FY2024-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 5 July 2024, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to the Company’s directors, executive officers and employees, including employees seconded to the Company’s subsidiaries, as well as directors of the Company’s subsidiaries, as set out below.」
A resolution was passed on 5 July 2024 to grant 11,095 stock acquisition rights of the seventh series to directors, executive officers, employees and directors of subsidiaries. The exercise period runs from 6 July 2026 to 5 July 2029. - FY2024-Q1AdvancedAnnual report
「In addition, 44,500 shares decreased in connection with the exercise of stock acquisition rights. As a result, the number of treasury shares was 262,265 as of the end of the first quarter accounting period.」
The number of treasury shares decreased by 44,500 in connection with the exercise of stock acquisition rights. - FY2023AdvancedAnnual report
「Exercised during the period (shares) 250,200 Balance outstanding at period-end (shares) 430,300」
In FY2023, stock options covering 201,700 shares were exercised, leaving 228,600 shares outstanding at period-end. - FY2023-Q3AdvancedAnnual report
「In addition, 45,000 shares decreased in connection with the exercise of stock acquisition rights. As a result, the number of treasury shares was 348,422 as of the end of the third quarter accounting period.」
Treasury shares decreased by 45,000 as a result of exercising stock acquisition rights. - FY2023-Q2AdvancedAnnual report
「In addition, 78,600 shares decreased in connection with the exercise of stock acquisition rights.」
The number of treasury shares decreased by 78,600 as a result of exercising stock acquisition rights. - FY2023-Q1AdvancedAnnual report
「In addition, 36,400 shares decreased in connection with the exercise of stock acquisition rights.」
The number of treasury shares decreased by 36,400 as a result of exercising stock acquisition rights. - FY2022AdvancedAnnual report
「Exercised during the period (shares) 250,200 Balance outstanding at period-end (shares) 430,300」
Stock options covering 250,200 shares were exercised during the fiscal year, leaving 430,300 shares outstanding at period-end. - FY2020AdvancedAnnual report
「Exercised during the period (shares) 88,500 Expired during the period (shares) 106,200 Balance outstanding at period-end (shares) —」
Of the fifth series of stock acquisition rights, 88,500 shares were exercised and 106,200 shares expired, leaving no balance outstanding at period-end. - FY2020-Q3AdvancedAnnual report
「1 June 2020 to 31 August 2020 7,000 48,642,300 3,563 6,603,767 3,563 6,687,242 (Note) Increase resulting from the exercise of stock acquisition rights.」
The total number of issued shares increased by 7,000 from June to August 2020 as a result of exercising stock acquisition rights. - FY2020-Q1AdvancedAnnual report
「1 December 2019 to 29 February 2020 40,000 48,635,300 20,360 6,600,204 20,360 6,683,679 (Note) Increase resulting from the exercise of stock options.」
The total number of issued shares increased by 40,000 from December 2019 to February 2020 as a result of stock option exercises. - FY2019-Q3AdvancedAnnual report
「1 June 2019 to 31 August 2019 (Note) 8,500 48,557,300 6,560,502 6,643,977 (Note) Increase resulting from the exercise of stock options.」
The total number of issued shares increased by 8,500 from June to August 2019 as a result of stock option exercises. - FY2019-Q2First statedAnnual report
「7 directors of the Company, including 2 outside directors; 5 executive officers of the Company; 264 employees of the Company; and 4 directors of the Company’s subsidiaries. Number of stock acquisition rights: 7,250 (Note 1). Class, details and number of shares underlying the stock acquisition rights: common shares, 725,000 shares (Note 1). Exercise period: 1 May 2021 to 25 April 2024.」
A resolution was passed to grant stock acquisition rights to directors, executive officers, employees and directors of subsidiaries, covering 7,250 rights and 725,000 underlying shares. The exercise period runs from 1 May 2021 to 25 April 2024.